FindTrial
Sign In

A medical records based study for summary of treatment experience in a single center of IgG4-associated sclerosing cholangitis

Treatment experience in a single center of IgG4-associated sclerosing cholangitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032612
Enrollment
Unknown
Registered
2020-05-04
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4-associated sclerosing cholangitis

Interventions

PHC group:None
IgG4-SC group:None

Sponsors

Department of Biliary Surgery, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
26 Years to 72 Years

Inclusion criteria

Inclusion criteria: All patients with benign disease who underwent curative resection for presumed PHC in our center from January 2010 to December 2019 were identified. Their bile duct specimens were re-evaluated by an independent pathologist and scored according to International Consensus Pathology Criteria for IgG4-related Disease (ICPD).

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Clinical symptoms;Demographic information;Imaging data;Pathological diagnosis;Operative record;Complications;—

Countries

China

Contacts

Public ContactLei Feng

Department of Biliary Surgery, West China Hospital, Sichuan University

743538823@qq.com+86 18780240137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026